申请人:Zhou Ming-Ming
公开号:US20140066410A1
公开(公告)日:2014-03-06
This disclosure relates generally to compounds and compositions comprising one or more diphenylethylene, diphenylethylyne, and azobenzene analogs. These compounds are useful for treating diseases associated with NF-kB and p53 activity, such as cancer and inflammatory disease.
本公开涉及一种化合物和组合物,其中包括一种或多种二苯乙烯,二苯乙炔和偶氮苯类似物。这些化合物可用于治疗与NF-kB和p53活性相关的疾病,如癌症和炎症性疾病。